ClinicalTrials.gov
public full text
Public Domain
Everolimus in de Novo Heart Transplant Recipients
The purpose of this study, in de novo heart transplant patients, is to evaluate whether delayed introduction of everolimus reduces the occurrence of wound healing problems, pericardial and/or pleural effusion and early acute renal insufficiency, as compared with immediate introduction of everolimus, in the firs six months after heart transplantation.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Commentary on: Outcomes of Intravenous Normal Saline Infusion Pre‐Cardiac Implantable Electronic Devices Versus no Infusion in Fasting#1090236
- Systemic Treatment With Everolimus for the Prevention of MACE After Bare Metal Stent Implantation#894615
- Clinical course and outcomes of antibody-mediated rejection after heart transplant in the contemporary era#294013
- Everolimus on CKD Progression in ADPKD Patients#1007249
- Rapid Response VA-ECMO in Refractory Out-of-hospital Cardiac Arrest#870413
Record · ID 839170
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive